Marc Barrillon
About the speaker
Marc Barrillon, has over 14 years of international experience at Büchi, a global leader in laboratory technology.
Throughout his career, he has developed a strong cross-functional expertise, evolving from field sales to product management, and currently serving as Area Business Manager.
In his current role, Marc is responsible for driving business development across key scientific markets including pharmaceuticals, academia, feed & food, and environmental analysis, working closely with a broad network of partners and distributors across multiple countries.
His professional background combines in-depth customer understanding with strategic market development, enabling him to effectively bridge the gap between scientific innovation and practical application. He is particularly engaged in supporting the adoption of advanced analytical solutions in complex and multidisciplinary environments.
Marc brings a pragmatic, results-oriented approach, leveraging his international experience and market insight to contribute to the advancement of data-driven practices and the continuous evolution of scientific industries.
Presentations
The transformation of liquid formulations into stable solid dosage forms is a critical step in pharmaceutical development. Among the available drying technologies, spray drying and freeze-drying (lyophilization) have emerged as two of the most widely used approaches, each offering distinct advantages depending on the therapeutic modality, formulation requirements, and product lifecycle objectives.
This presentation provides a comparative overview of these two technologies, highlighting their underlying principles, process characteristics, and impact on critical quality attributes. The discussion will explore how spray drying enables particle engineering, bioavailability enhancement, and the development of amorphous solid dispersions, while lyophilization remains the preferred technology for preserving the stability and biological activity of sensitive molecules such as proteins, peptides, and vaccines.
Through practical pharmaceutical examples, attendees will gain insight into the key criteria driving technology selection, including drug properties, stability requirements, scalability, and cost considerations. The presentation aims to provide a balanced perspective on when and why each technology should be considered, emphasizing that spray drying and freeze-drying are often complementary tools within the pharmaceutical development toolbox rather than competing solutions.
Key takeaway: Selecting the appropriate drying technology requires aligning product needs, formulation strategy, and manufacturing objectives to achieve optimal quality, stability, and patient outcomes.